NDLI: Antigenic structure of envelope glycoprotein E1 of hog cholera virus.

Please wait, while we are loading the content...

Year: 2016, Volume: 90

Year: 2015, Volume: 90

Year: 2015, Volume: 89

Year: 2014, Volume: 89

Year: 2014, Volume: 88

Year: 2013, Volume: 87

Year: 2012, Volume: 86

Year: 2011, Volume: 85

Year: 2010, Volume: 84

Year: 2009, Volume: 83

Year: 2008, Volume: 82

Year: 2007, Volume: 81

Year: 2006, Volume: 80

Year: 2005, Volume: 79

Year: 2004, Volume: 78

Year: 2003, Volume: 77

Year: 2002, Volume: 76

Year: 2001, Volume: 75

Year: 2000, Volume: 74

Year: 1999, Volume: 73

Year: 1998, Volume: 72

Year: 1997, Volume: 71

Year: 1996, Volume: 70

Year: 1995, Volume: 69

Year: 1994, Volume: 68

Year: 1994, Volume: 68, Issue: 12

Year: 1994, Volume: 68, Issue: 11

Year: 1994, Volume: 68, Issue: 10

Year: 1994, Volume: 68, Issue: 9

Year: 1994, Volume: 68, Issue: 8

Year: 1994, Volume: 68, Issue: 7

Year: 1994, Volume: 68, Issue: 6

VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells.

Alteration of V3 loop context within the envelope of human immunodeficiency virus type 1 enhances neutralization.

The apoptotic suppressor P35 is required early during baculovirus replication and is targeted to the cytosol of infected cells.

Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity.

Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes.

Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells.

Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses.

Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.

Preexisting nuclear architecture defines the intranuclear location of herpesvirus DNA replication structures.

Analysis of AP-1 function in cellular transformation pathways.

Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer.

Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.

Construction of rubella virus genome-length cDNA clones and synthesis of infectious RNA transcripts.

In vitro activities of purified visna virus integrase.

Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63.

Specific interaction between the bovine papillomavirus E5 transforming protein and the beta receptor for platelet-derived growth factor in stably transformed and acutely transfected cells.

Identification of an immediate-early gene in the Marek's disease virus long internal repeat region which encodes a unique 14-kilodalton polypeptide.

Mapping and characterization of antigenic epitopes and the nucleic acid-binding domains of the VP6 protein of bluetongue viruses.

Transcriptional silencer of the human papillomavirus type 8 late promoter interacts alternatively with the viral trans activator E2 or with a cellular factor.

Changes in RNA expression pattern during the malignant progression of cottontail rabbit papillomavirus-induced tumors in rabbits.

Biosynthesis and biochemical properties of the hepatitis C virus core protein.

The vaccinia virus A18R protein plays a role in viral transcription during both the early and the late phases of infection.

Vesicular stomatitis virus Indiana glycoprotein as a T-cell-dependent and -independent antigen.

Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: a study of coronavirus transcription initiation.

Apoptosis: a mechanism of cell killing by influenza A and B viruses.

Cloning and expression of an equine herpesvirus 1 origin-binding protein.

The "V3" domain is a determinant of simian immunodeficiency virus cell tropism.

Helicase-primase complex of herpes simplex virus type 1: a mutation in the UL52 subunit abolishes primase activity.

The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth.

Uncoating of human rhinovirus serotype 2 from late endosomes.

Dissociation of retinoblastoma gene protein hyperphosphorylation and commitment to enter S phase.

Herpes simplex virus type 1 recombination: the Uc-DR1 region is required for high-level a-sequence-mediated recombination.

Proteolytic activity of human cytomegalovirus UL80 protease cleavage site mutants.

Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins.

Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene.

Origins of enhancer sequences of recombinant murine leukemia viruses from spontaneous B- and T-cell lymphomas of CWD mice.

Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.

NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies.

Genetic analysis indicates that the human foamy virus Bel-1 protein contains a transcription activation domain of the acidic class.

Localization of a 34-amino-acid segment implicated in dimerization of the herpes simplex virus type 1 ICP4 polypeptide by a dimerization trap.

Products of the porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR.

Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus.

Expression of the varicella-zoster virus origin-binding protein and analysis of its site-specific DNA-binding properties.

Cellular protein modulates effects of human immunodeficiency virus type 1 Rev.

A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses.

Identification and characterization of a novel structural glycoprotein in pseudorabies virus, gL.

Identification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus.

Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes.

Substrate features important for recognition and catalysis by human immunodeficiency virus type 1 integrase identified by using novel DNA substrates.

Adenovirus type 9 E4 open reading frame 1 encodes a transforming protein required for the production of mammary tumors in rats.

Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses.

Antigenic structure of envelope glycoprotein E1 of hog cholera virus.

UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression.

Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure.

Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.

Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.

Interactions among the major and minor coat proteins of polyomavirus.

Deletion mapping of the rotavirus metalloprotein NS53 (NSP1): the conserved cysteine-rich region is essential for virus-specific RNA binding.

Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodies.

Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow.

Sendai virus pneumonia: evidence for the early recruitment of gamma delta T cells during the disease course.

Induction of tetraploid DNA content by simian virus 40 is dependent on T-antigen function in the G2 phase of the cell cycle.

Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS.

Trichomonas vaginalis with a double-stranded RNA virus has upregulated levels of phenotypically variable immunogen mRNA.

Glycosylphosphatidylinositol-anchored CD4 supports human immunodeficiency virus type 1 replication, but not cytopathic effect, in T-cell transfectants.

T-cell response to cottontail rabbit papillomavirus structural proteins in infected rabbits.

FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus.

A Friend virus mutant encodes a small glycoprotein that causes erythroleukemia.

Constitutive production of alpha and beta interferons in mutant human cell lines.

The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus.

Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus.

A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1.

Persistence of simian immunodeficiency virus Mne variants upon transmission.

Expression and characterization of virus-like particles containing rubella virus structural proteins.

The influenza virus panhandle is involved in the initiation of transcription.

Copackaging of different-sized retroviral genomic RNAs: little effect on retroviral replication or recombination.

Cell-binding domain of adenovirus serotype 2 fiber.

Binding of the Protease-Sensitive Form of PrP (Prion Protein) to Sulfated Glycosaminoglycan and Congo Red

Identification and Characterization of a Human Herpesvirus 6 Gene Segment Capable of Transactivating the Human Immunodeficiency Virus Type 1 Long Terminal Repeat in an Sp1 Binding Site-Dependent Manner

Year: 1994, Volume: 68, Issue: 5

Year: 1994, Volume: 68, Issue: 4

Year: 1994, Volume: 68, Issue: 3

Year: 1994, Volume: 68, Issue: 2

Year: 1994, Volume: 68, Issue: 1

Year: 1993, Volume: 67

Year: 1992, Volume: 66

Year: 1991, Volume: 65

Year: 1990, Volume: 64

Year: 1989, Volume: 63

Year: 1988, Volume: 62

Year: 1987, Volume: 61

Year: 1986, Volume: 60

Year: 1986, Volume: 59

Year: 1986, Volume: 58

Year: 1986, Volume: 57

Year: 1985, Volume: 56

Year: 1985, Volume: 55

Year: 1985, Volume: 54

Year: 1985, Volume: 53

Year: 1984, Volume: 52

Year: 1984, Volume: 51

Year: 1984, Volume: 50

Year: 1984, Volume: 49

Year: 1983, Volume: 48

Year: 1983, Volume: 47

Year: 1983, Volume: 46

Year: 1983, Volume: 45

Year: 1982, Volume: 44

Year: 1982, Volume: 43

Year: 1982, Volume: 42

Year: 1982, Volume: 41

Year: 1981, Volume: 40

Year: 1981, Volume: 39

Year: 1981, Volume: 38

Year: 1981, Volume: 37

Year: 1980, Volume: 36

Year: 1980, Volume: 35

Year: 1980, Volume: 34

Year: 1980, Volume: 33

Year: 1979, Volume: 32

Year: 1979, Volume: 31

Year: 1979, Volume: 30

Year: 1979, Volume: 29

Year: 1978, Volume: 28

Year: 1978, Volume: 27

Year: 1978, Volume: 26

Year: 1978, Volume: 25

Year: 1977, Volume: 24

Year: 1977, Volume: 23

Year: 1977, Volume: 22

Year: 1977, Volume: 21

Year: 1976, Volume: 20

Year: 1976, Volume: 19

Year: 1976, Volume: 18

Year: 1976, Volume: 17

Year: 1975, Volume: 16

Year: 1975, Volume: 15

Year: 1974, Volume: 14

Year: 1974, Volume: 13

Year: 1973, Volume: 12

Year: 1973, Volume: 11

Year: 1972, Volume: 10

Year: 1972, Volume: 9

Year: 1971, Volume: 8

Year: 1971, Volume: 7

Year: 1970, Volume: 6

Year: 1970, Volume: 5

Year: 1969, Volume: 4

Year: 1969, Volume: 3

Year: 1968, Volume: 2

Year: 1967, Volume: 1

Antigenic structure of envelope glycoprotein E1 of hog cholera virus.

Content Provider	PubMed Central
Author	Rijn, P. A. Van Miedema, G. K. Wensvoort, G. Gennip, H. G. Van Moormann, R. J.
Abstract	Envelope glycoprotein E1 (gp51 to gp54) is the most antigenic protein of hog cholera virus or classical swine fever virus (CSFV). Four antigenic domains, A to D, have been mapped on E1 with a panel of monoclonal antibodies (MAbs) raised against CSFV strain Brescia. The boundaries of these domains have been established by extensive studies on binding of MAbs to transiently expressed deletion mutants of E1 (P. A. van Rijn, E. J. de Meijer, H. G. P. van Gennip, and R. J. M. Moormann, J. Gen. Virol. 74:2053-2060, 1993). In this study, we used neutralizing MAbs of domains A, B, and C to isolate MAb-resistant mutants (MAR mutants) of CSFV strain Brescia and Chinese vaccine strain ("C"). The E1 genes of MAR mutants were cloned in a eukaryotic expression vector, and the effects of MAR mutations on epitopes were studied with a panel of 19 MAbs by immunostaining of COS1 cells transiently expressing these mutant E1s. Except for the MAR mutation Cys-->Arg at position 792, which abolished binding of all MAbs of domains A and D, amino acid substitutions affected only MAbs belonging to the same domain as the MAb used to select the MAR mutant. However, a MAR mutation in a particular domain did not per se abolish binding of all MAbs recognizing that domain. Furthermore, MAR mutants possessed conservative as well as nonconservative amino acid substitutions. To investigate the significance of a secondary structure for the binding of MAbs, all cysteine residues in the N-terminal antigenic part of E1 were mutated to serine. We found that the cysteines at positions 693 and 737 were essential for binding by MAbs of domains B and C, whereas those at positions 792, 818, 828, and 856 appeared to be essential for the binding of most MAbs of domains A and D. These results fully comply with the previously proposed two-unit structure of the N-terminal half of E1. One unit consists of antigenic domains B and C, whereas the other unit consists of the highly conserved domain A and domain D. We conclude that the first six cysteines are critical for the correct folding of E1. A model of the antigenic structure of E1 is presented and discussed.
Starting Page	3934
File Format	PDF
ISSN	10985514
e-ISSN	10985514
Journal	Journal of Virology
Issue Number	6
Volume Number	68
Language	English
Publisher Date	1994-06-01
Access Restriction	Open
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Virology Immunology Microbiology Insect Science

Central Library (ISO-9001:2015 Certified)
Indian Institute of Technology Kharagpur
Kharagpur, West Bengal, India | PIN - 721302

See location in the Map
03222 282435
Mail: support@ndl.gov.in

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in